{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:43:50Z","timestamp":1772894630983,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T00:00:00Z","timestamp":1138838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00262-006-0133-y","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T15:22:12Z","timestamp":1138807332000},"page":"1320-1329","source":"Crossref","is-referenced-by-count":37,"title":["Expression of macrophage-derived chemokine (MDC)\/CCL22 in human lung cancer"],"prefix":"10.1007","volume":"55","author":[{"given":"Toru","family":"Nakanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naozumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Shimokata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,2]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/annonc\/mdh051","volume":"15","author":"RC Winterhalder","year":"2004","unstructured":"Winterhalder RC, Hirsch FR, Kotantoulas GK, Franklin WA, Bunn PA Jr (2004) Chemoprevention of lung cancer\u2014from biology to clinical reality. Ann Oncol 15:185\u2013196","journal-title":"Ann Oncol"},{"key":"133_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.lungcan.2004.01.017","volume":"45","author":"F Rea","year":"2004","unstructured":"Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, Sartori F (2004) Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer 45:215\u2013220","journal-title":"Lung Cancer"},{"key":"133_CR3","doi-asserted-by":"crossref","unstructured":"Frederick MJ, Clayman GL (2001) Chemokines in cancer. Expert Rev Mol Med 2001:1\u201318","DOI":"10.1017\/S1462399401003301"},{"key":"133_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1185\/030079903125002216","volume":"19","author":"M Arya","year":"2003","unstructured":"Arya M, Patel HRH, Williamson M (2003) Chemokines: key players in cancer. Curr Med Res Opin 19:557\u2013564","journal-title":"Curr Med Res Opin"},{"key":"133_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semcancer.2003.10.007","volume":"14","author":"J Damme Van","year":"2004","unstructured":"Van Damme J, Struyf S, Opdenakker G (2004) Chemokine-protease interactions in cancer. Semin Cancer Biol 14:201\u2013208","journal-title":"Semin Cancer Biol"},{"key":"133_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1387\/ijdb.041796go","volume":"48","author":"G Opdennakker","year":"2004","unstructured":"Opdennakker G, van Damme J (2004) The countercurrent principle in invasion and metastasis of cancer cells. recent insights on the roles of chemokines. Int J Dev Biol 48:519\u2013527","journal-title":"Int J Dev Biol"},{"key":"133_CR7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1164\/ajrccm.164.7.2103011","volume":"164","author":"D D\u2019Ambrosio","year":"2001","unstructured":"D\u2019Ambrosio D, Mariani M, Panina-Bordignon P, Sinigaglia F (2001) Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 164:1266\u20131275","journal-title":"Am J Respir Crit Care Med"},{"key":"133_CR8","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.162.6.3549","volume":"162","author":"A Sauty","year":"1999","unstructured":"Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD (1999) The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 162:3549\u20133558","journal-title":"J Immunol"},{"key":"133_CR9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0002-9440(10)64101-6","volume":"158","author":"B Qiu","year":"2001","unstructured":"Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW (2001) Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 158:1503\u20131515","journal-title":"Am J Pathol"},{"key":"133_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.1679","volume":"205","author":"ED Carlo","year":"2005","unstructured":"Carlo ED, Cappello P, Sorrentino C, D\u2019Antuono T, Pellicciotta A, Giovarelli M, Forni G, Musiani P, Triebel F (2005) Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway. J Pathol 205:82\u201391","journal-title":"J Pathol"},{"key":"133_CR11","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.165.4.2205","volume":"165","author":"T Sekiya","year":"2000","unstructured":"Sekiya T, Miyamasu M, Imanishi M, Yamada H, Nakajima T, Yamaguchi M, Fujisawa T, Pawankar R, Sano Y, Ohta K, Ishii A, Morita Y, Yamamoto K, Matsushima K, Yoshie O, Hirai K (2000) Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 165:2205\u20132213","journal-title":"J Immunol"},{"key":"133_CR12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2004.tb03248.x","volume":"95","author":"H Ikeda","year":"2004","unstructured":"Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T (2004) The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci 95:697\u2013703","journal-title":"Cancer Sci"},{"key":"133_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.cgt.7700320","volume":"8","author":"M Noguchi","year":"2001","unstructured":"Noguchi M, Imaizumi K, Kawabe T, Wakayama H, Horio Y, Sekido Y, Hara T, Hashimoto N, Takahashi M, Shimokata K, Hasegawa Y, (2001) Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer. Cancer Gene Ther 8:421\u2013429","journal-title":"Cancer Gene Ther"},{"key":"133_CR14","first-page":"853","volume":"9","author":"ES White","year":"2003","unstructured":"White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9:853\u2013860","journal-title":"Clin Cancer Res"},{"key":"133_CR15","first-page":"7451","volume":"63","author":"P Monti","year":"2003","unstructured":"Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, Piemonti L (2003) The CC chemokine MCP-1\/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res 63:7451\u20137461","journal-title":"Cancer Res"},{"key":"133_CR16","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1038\/sj.onc.1207097","volume":"22","author":"M Burger","year":"2003","unstructured":"Burger M, Glodek A, Hartmann T, Schmitt-Graff A, Silberstein LE, Fujii N, Kipps TJ, Burger JA (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22:8093\u20138101","journal-title":"Oncogene"},{"key":"133_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(89)90925-2","volume":"57","author":"RI Tepper","year":"1989","unstructured":"Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503\u2013512","journal-title":"Cell"},{"key":"133_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02967457","volume":"7","author":"S Nagai","year":"2000","unstructured":"Nagai S, Toi M (2000) Interleukin-4 and breast cancer. Breast Cancer 7:181\u2013186","journal-title":"Breast Cancer"},{"key":"133_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.gt.3301688","volume":"9","author":"J Guo","year":"2002","unstructured":"Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X (2002) Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther 9:793\u2013803","journal-title":"Gene Ther"},{"key":"133_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00002371-200303000-00004","volume":"26","author":"JM Lee","year":"2003","unstructured":"Lee JM, Merritt RE, Mahtabifard A, Yamada R, Kikuchi T, Crystal RG, Korst RJ (2003) Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice. J Immunother 26:117\u2013129","journal-title":"J Immunother"},{"key":"133_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood.V98.3.533","volume":"98","author":"P Ghia","year":"2001","unstructured":"Ghia P, Transidico P, Veiga JP, Schaniel C, Sallusto F, Matsushima K, Sallan SE, Rolink AG, Mantovani A, Nadler LM, Cardoso AA (2001) Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood 98:533\u2013540","journal-title":"Blood"},{"key":"133_CR22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.306.5698.966","volume":"306","author":"J Marx","year":"2004","unstructured":"Marx J (2004) Inflammation and cancer: the link grows stronger. Science 306:966\u2013968","journal-title":"Science"},{"key":"133_CR23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin EY, Nguyen AV, Russell GR, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727\u2013740","journal-title":"J Exp Med"},{"key":"133_CR24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20021047","volume":"197","author":"D Daniel","year":"2003","unstructured":"Daniel D, Meyer-Morse N, Bergsland EK, Dehne K, Coussens LM, Hanahan D (2003) Immune enhancement of skin carcinogenesis by CD4+ T cells. J Exp Med 197:1017\u20131028","journal-title":"J Exp Med"},{"key":"133_CR25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.184.3.981","volume":"184","author":"DA Arenberg","year":"1996","unstructured":"Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM (1996) Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 184:981\u2013992","journal-title":"J Exp Med"},{"key":"133_CR26","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/01.ju.0000127726.25609.87","volume":"171","author":"T Kondo","year":"2004","unstructured":"Kondo T, Ito F, Nakazawa H, Horita S, Osaka Y, Toma H (2004) High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma.. J Urol 171:2171\u20132175","journal-title":"J Urol"},{"key":"133_CR27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2004.03.013","volume":"317","author":"N Okada","year":"2004","unstructured":"Okada N, Gao JQ, Sasaki A, Niwa M, Okada Y, Nakayama T, Yoshie O, Mizuguchi H, Hayakawa T, Fujita T, Yamamoto A, Tsutsumi Y, Mayumi T, Nakagawa S (2004) Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host\u2019s immune system: implications for chemokine-based cancer immunotherapy. Biochem Biophys Res Commun 317:68\u201376","journal-title":"Biochem Biophys Res Commun"},{"key":"133_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1165\/ajrcmb.24.4.4360","volume":"24","author":"MC Berin","year":"2001","unstructured":"Berin MC, Eckmann L, Broide DH, Kagnoff MF (2001) Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 24:382\u2013389","journal-title":"Am J Respir Cell Mol Biol"},{"key":"133_CR29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949","journal-title":"Nat Med"},{"key":"133_CR30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"R Arriagada","year":"2004","unstructured":"Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351\u2013360","journal-title":"N Engl J Med"},{"key":"133_CR31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa032792","volume":"350","author":"H Kato","year":"2004","unstructured":"Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713\u20131721","journal-title":"N Engl J Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-006-0133-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-006-0133-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-006-0133-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:41:59Z","timestamp":1683369719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-006-0133-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,2]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1007\/s00262-006-0133-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,2]]}}}